Guard Therapeutics: Data collection in phase IIb study POINTER completed - Redeye
Bildkälla: Stockfoto

Guard Therapeutics: Data collection in phase IIb study POINTER completed - Redeye

Redeye briefly comments on Guard announcing that the data collection for the phase IIb study POINTER has been completed.

Redeye briefly comments on Guard announcing that the data collection for the phase IIb study POINTER has been completed.
Börsvärldens nyhetsbrev